Abstract
Background: The high prevalence of drug-related problems (DRPs) in the elderly, occurring as a result of multiple drug use combined with age-related changes in pharmacokinetics and pharmacodynamics, is a well known phenomenon. However, effective intervention strategies are uncommon. Objective: A pharmacy-based controlled trial (SMOG [Screening Medicatie Oudere Geneesmiddelgebruiker; Screening Medications in the Older Drug User]) was performed to investigate whether a community pharmacist-led intervention reduces the number of potential DRPs in patients aged ≥65 years using six or more drugs concomitantly.
Methods: This intervention study was conducted from June 2002 until June 2003 in 16 community pharmacies in the Netherlands. Medication assessment was undertaken in elderly patients aged ≥65 years using six or more drugs concomitantly on the date of inclusion. Ten types of potential DRPs were determined and grouped into the following three categories: (i) patient-related potential DRPs: non-compliance; (ii) prescriber-related potential DRPs: expired indication, therapeutic duplication, inappropriate dosage (over- and under-dosage), off-label use, undertreatment, inconvenience of use; and (iii) drug-related potential DRPs: contraindications, drug-drug interactions, drug treatment of adverse drug reactions.
A list of recommended changes in medication was compiled by the pharmacist for the patients in the intervention group. Recommendations for medication change were discussed with the general practitioner (GP). Four months after the date of inclusion, the medications of each patient were again reviewed and screened for potential DRPs. The primary outcome corresponded to the change in the number of potential DRPs; the secondary outcome was related to the change in number of used medications between the intervention group and the control group at baseline and 4 months later.
Results: A total of 174 patients were analysed: 87 patients in the intervention arm and 87 patients in the usual care arm. After a 4-month period, we observed a significant reduction in the mean number of DRPs per patient (mean difference −16.3%; 95% CI −24.3, −8.3). The mean number of drugs per patient was not significantly reduced (mean difference −4.7%; 95% CI −9.6, 0.2).
Conclusion: This study showed a positive influence of the community pharmacist in reducing potential DRPs in the elderly. Future interventions should also focus on actual outcomes, including quality of life, morbidity and mortality.
Similar content being viewed by others
References
Central Office for Statistics [online]. Available from URL: http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLNL&PA=03766ned&D1=a&D2=0&D3=l,4,14,24,34,1&HD=090115-1023&HDR=G1,G2&STB=T [Accessed 2008 Dec 20]
Data en feiten 2006. Stichting Farmaceutische Kengetallen. July 2006; 16 [online]. Available from URL: http://www.sfk.nl/publicaties/2006denf.pdf [Accessed 2009 Jan 27]
Walker J, Wynne H. Review: the frequency and severity of adverse drug reactions in elderly people. Age Ageing 1994; 23(3): 255–9
Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329(7456): 15–9
Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57(1): 6–14
Strand LM, Morley PC, Cipolle RJ, et al. Drug-related problems: their structure and function. DICP 1990; 24(11): 1093–7
Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002; 24(4): 120–7
van Mil JW, Westerlund LO, Hersberger KE, et al. Drug-related problem classification systems. Ann Pharmacother 2004; 38(5): 859–67
Vinks TH, de Koning FH, de Lange TM, et al. Identification of potential drug-related problems in the elderly: the role of the community pharmacist. Pharm World Sci 2006; 28(1): 33–8
Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289 (9): 1107–16
Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004; 164(3): 305–12
Hanlon JT, Artz MB, Pieper CF, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004; 38(1): 9–14
Hanlon JT, Lindblad CI, Gray SL. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am J Geriatr Pharmacother 2004; 2(1): 3–13
Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100(4): 428–37
Zermansky AG, Petty DR, Raynor DK, et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323(7325): 1340–3
Holland R, Lanaghan E, Harvey I, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ 2005; 330(7486): 293–7
Anatomical Therapeutic Chemical (ATC) classification system. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2003
Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992; 45(2): 197–203
Johnson RE, Hornbrook MC, Nichols GA. Replicating the chronic disease score (CDS) from automated pharmacy data. J Clin Epidemiol 1994; 47(10): 1191–9
Clark DO, Von Korff M, Saunders K, et al. A chronic disease score with empirically derived weights. Med Care 1995; 33(8): 783–95
Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging 2003; 20(11): 817–32
Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 2006 Nov; 35(6): 586–91
Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531–6
Kassam R, Martin LG, Farris KB. Reliability of a modified medication appropriateness index in community pharmacies. Ann Pharmacother 2003; 37: 40–6
Ko DT, Mamdani M, Alter DA. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 2004; 291(15): 1864–70
Lee DS, Tu JV, Juurlink DN, et al. Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA 2005; 294(10): 1240–7
Bajorek BV, Krass I, Ogle SJ, et al. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention. J Am Geriatr Soc 2005;53(11): 1912–20
Pugh MJ, Lindblad CI, Handler SM, et al. Update on drugrelated problems in the elderly. Am J Geriatr Pharmacother 2005; 3(3): 205–10
Kroenke K, Pinholt EM. Reducing polypharmacy in the elderly: a controlled trial of physician feedback. J Am Geriatr Soc 1990; 38(1): 31–6
Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 2005; 22(1): 69–82
Lau DT, Kasper JD, Potter DE, et al. Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents. Arch Intern Med 2005; 165(1): 68–74
Sondergaard J, Goged A, Kragstrup J, et al. Intensive community pharmacy intervention had little impact on triptan consumption: a randomized controlled trial. Scand J Prim Health Care 2006; 24(1): 16–21
Salter C, Holland R, Harvey I, et al. “I haven’t even phoned my doctor yet”. The advice giving role of the pharmacist during consultations for medication review with patients aged 80 or more: qualitative discourse analysis. BMJ 2007; 334(7603): 1101–6
Wu JY, Leung WY, Chang S, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomised controlled trial. BMJ 2006; 333(7567): 522–7
Holland R, Brooksby I, Lenaghan E, et al. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ 2007; 334 (7603): 1066–7
Acknowledgements
The authors would like to thank the participating Brabant Institute for pharmaceutical Research and Development (BIRD) and Kring Pharmacies pharmacists for their contribution to this study. The authors are also grateful to Alliance Healthcare and VGZ (a Dutch health insurance company) for their support. This study was partly financed by an educational grant from the Dutch Albert Bakker Foundation. The authors have no conflicts of interest that are directly relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vinks, T.H.A.M., Egberts, T.C.G., de Lange, T.M. et al. Pharmacist-Based Medication Review Reduces Potential Drug-Related Problems in the Elderly. Drugs Aging 26, 123–133 (2009). https://doi.org/10.2165/0002512-200926020-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/0002512-200926020-00004